Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine effect on propofol induction dose during gastroscopy in high-risk OSA patients
ChiCTR2400088569Phase 4Not yet recruiting
- Sponsor
- Beijing Friendship Hospital
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of propofol in None and obstructive sleep apnea hypopnea syndrome (OSAHS) (2 arms), sponsored by Beijing Friendship Hospital. Primary endpoint: ED50 and ED95 of propofol. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
propofol
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on ChiCTR2400088569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400088569.